A Phase 2a, Open-Label, Proof -of-Concept Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures.
Phase of Trial: Phase II
Latest Information Update: 02 Sep 2014
At a glance
- Drugs Clonazepam (Primary)
- Indications Seizures
- Focus Proof of concept; Therapeutic Use
- Sponsors Jazz Pharmaceuticals Inc
- 08 Mar 2011 According to a Jazz Pharmaceuticals SEC form 10-K Annual Report, preliminary findings of this trial were positive.
- 11 Jun 2008 This trial is expected to be completed in 2008, according to a Jazz Pharmaceuticals media release.
- 08 Jan 2008 FDA Orphan Drug Designation received.